A report yesterday from the United Kingdom's Food Standards Agency (FSA) shows that that the prevalence of antibiotic-resistant Escherichia coli in retail beef and pork samples remains low.
An increase in resistance to ciprofloxacin among poultry isolates was primarily due to Salmonella Infantis.
Three new studies to be presented at the upcoming European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) conference at the end of the month demonstrate benefits of the antiviral molnupiravir against COVID-19 infections, including evidence that Merck's pill reduces symptoms of the SARS-CoV-2 virus by day 3 of administration.
The Indiana Board of Animal Health (IBAH) said today that initial tests at a third turkey farm in the state are positive for H5 avian flu. The new detection marks the United States' fifth recent outbreak in poultry. Further testing is under way to assess if the virus is the same highly pathogenic H5N1 strain that struck the first Indiana farm.
A 3-year prospective audit and feedback (PAF) intervention led by pharmacists at a Japanese hospital was linked to reduced antibiotic duration and more appropriate antibiotic use in patients with Escherichia coli bacteremia, Japanese researchers reported yesterday in the American Journal of Infection Control.
Danish microbiome technology company SNIPR Biome ApS announced this week that the US Food and Drug Administration has approved the company's application to initiate the first human clinical trial of its CRISPR-based drug for preventing Escherichia coli infections in cancer patients.
Late last week the US Centers for Disease Control and Prevention (CDC) posted an outbreak notice about an Escherichia coli O157:H7 outbreak related to mixed leafy greens.
Antibiotic prescribing for respiratory tract infections (RTIs) fell in England during the first year of the pandemic, researchers reported today in the Journal of Antimicrobial Chemotherapy.
An automated text messaging system for adult COVID-19 outpatients developed at Penn Medicine saved two lives a week during the first US pandemic surge, and users were 68% less likely than controls to die, finds a study today in the Annals of Internal Medicine.
Of 1,061 people who were hesitant about receiving the COVID-19 vaccine at the end of 2020, 32% were at least partially vaccinated by spring 2021, and 37% said they were likely to be, according to a research letter published today in JAMA Network Open.